Literature DB >> 24429370

Adenovirus serotype 26 and 35 vectors induce simian immunodeficiency virus-specific T lymphocyte responses in foreskin in rhesus monkeys.

Emmanuel Balandya1, Andrew D Miller, Matthew Beck, Jinyan Liu, Hualin Li, Erica Borducchi, Kaitlin Smith, Crystal Cabral, Kelly Stanley, Lori F Maxfield, Dan H Barouch.   

Abstract

UNLABELLED: Foreskin is the principal site of heterosexual HIV-1 infection in men. However, little is known about HIV-1-specific immune responses or inflammation in foreskin. To the best of our knowledge, no previous studies have assessed immune responses to candidate HIV-1 vaccines in foreskin. Using the rhesus monkey model, we show that intramuscular immunization with adenovirus serotype 26 and 35 vectors expressing SIV antigens elicited durable SIV Gag-specific CD4(+) and CD8(+) T cell responses in foreskin that were detectable for more than 1 year following vaccination. Gag-specific CD4(+) and CD8(+) T cells were also detectable in foreskin of SIV- and SHIV-infected animals and were at least comparable in magnitude to those in peripheral blood. However, unlike peripheral blood T cells, the majority of foreskin T cells exhibited transitional memory or effector memory phenotype and expressed higher levels of the activation markers CD69, HLA-DR, and CCR5, although vaccination did not further enhance foreskin CD4(+) T cell activation. These findings suggest that systemic vaccination strategies can elicit potentially important SIV-specific cellular immunity in foreskin. Further characterization of vaccine-elicited immune responses and inflammation in foreskin is warranted. IMPORTANCE: We demonstrate here the induction of SIV-specific cellular immune responses in foreskin by adenovirus serotype 26 and 35 vaccine vectors. Foreskin T cells were more activated than peripheral blood T cells, but foreskin T cells were not further activated by vaccination. These findings suggest that alternative serotype adenovirus vectors induce potentially important immune responses in foreskin.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24429370      PMCID: PMC3993544          DOI: 10.1128/JVI.03771-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.

Authors:  F Sallusto; D Lenig; R Förster; M Lipp; A Lanzavecchia
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

2.  Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease.

Authors:  M J E Havenga; A A C Lemckert; O J A E Ophorst; M van Meijer; W T V Germeraad; J Grimbergen; M A van Den Doel; R Vogels; J van Deutekom; A A M Janson; J D de Bruijn; F Uytdehaag; P H A Quax; T Logtenberg; M Mehtali; A Bout
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates.

Authors:  Louis J Picker; Edward F Reed-Inderbitzin; Shoko I Hagen; John B Edgar; Scott G Hansen; Alfred Legasse; Shannon Planer; Michael Piatak; Jeffrey D Lifson; Vernon C Maino; Michael K Axthelm; Francois Villinger
Journal:  J Clin Invest       Date:  2006-05-11       Impact factor: 14.808

4.  Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.

Authors:  Ronald H Gray; Godfrey Kigozi; David Serwadda; Frederick Makumbi; Stephen Watya; Fred Nalugoda; Noah Kiwanuka; Lawrence H Moulton; Mohammad A Chaudhary; Michael Z Chen; Nelson K Sewankambo; Fred Wabwire-Mangen; Melanie C Bacon; Carolyn F M Williams; Pius Opendi; Steven J Reynolds; Oliver Laeyendecker; Thomas C Quinn; Maria J Wawer
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

5.  Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.

Authors:  Robert C Bailey; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; John N Krieger; Carolyn F M Williams; Richard T Campbell; Jeckoniah O Ndinya-Achola
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

6.  Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1.

Authors:  L J Walsh; G Trinchieri; H A Waldorf; D Whitaker; G F Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

7.  Potential HIV-1 target cells in the human penis.

Authors:  Scott G McCoombe; Roger V Short
Journal:  AIDS       Date:  2006-07-13       Impact factor: 4.177

8.  Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys.

Authors:  Jinyan Liu; Bonnie A Ewald; Diana M Lynch; Matthew Denholtz; Peter Abbink; Angelique A C Lemckert; Angela Carville; Keith G Mansfield; Menzo J Havenga; Jaap Goudsmit; Dan H Barouch
Journal:  J Virol       Date:  2008-03-12       Impact factor: 5.103

9.  Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.

Authors:  Bertran Auvert; Dirk Taljaard; Emmanuel Lagarde; Joëlle Sobngwi-Tambekou; Rémi Sitta; Adrian Puren
Journal:  PLoS Med       Date:  2005-10-25       Impact factor: 11.069

10.  Male circumcision significantly reduces prevalence and load of genital anaerobic bacteria.

Authors:  Cindy M Liu; Bruce A Hungate; Aaron A R Tobian; David Serwadda; Jacques Ravel; Richard Lester; Godfrey Kigozi; Maliha Aziz; Ronald M Galiwango; Fred Nalugoda; Tania L Contente-Cuomo; Maria J Wawer; Paul Keim; Ronald H Gray; Lance B Price
Journal:  mBio       Date:  2013-04-16       Impact factor: 7.867

View more
  2 in total

1.  Lymphatic Dissemination of Simian Immunodeficiency Virus after Penile Inoculation.

Authors:  Zhong-Min Ma; Joseph Dutra; Linda Fritts; Christopher J Miller
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

Review 2.  Non-Human Primate-Derived Adenoviruses for Future Use as Oncolytic Agents?

Authors:  Selas T F Bots; Rob C Hoeben
Journal:  Int J Mol Sci       Date:  2020-07-08       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.